In: personalized medicine

Slone Partners, Where People Are Our Science®, Places Lloyd Sanders As CEO At Epic Sciences, Inc.

Commercialization and marketing-focused C-suite executive specializing in oncology brings more than 20 years experience in diagnostics and pharmaceuticals industries  SAN FRANCISCO...

Karius

Slone Partners, Where People Are Our Science®, Places Michael Mercer as Chief Commercial Officer at Karius, Inc.

Mr. Mercer brings over 25 years of exceptional scientific healthcare leadership experience   San Francisco -December 4 – Slone Partners, North America’s...

SomaLogic

Slone Partners, Where People Are Our Science®, Places Roy Smythe, M.D. as Chief Executive Officer at SomaLogic, Inc.

World-class healthcare executive, former Global Chief Medical Officer of Strategy, Partnerships, and Informatics at healthcare powerhouse Royal Philips, is also a...

PMC Series: Interview with Bryce Olson, Global Strategist, Health and Life Sciences, Intel Corporation

Slone Partners’ 2018 PMC Interview Series concludes with an exclusive, in-depth interview with Bryce Olson, a Global Strategist at Intel Corporation’s...

PMC Series: Interview with Colin Hill, Chairman, CEO and Co-Founder of GNS Healthcare

Slone Partners’ 2018 PMC Interview Series enters its 4th week with an exclusive, in-depth interview with Colin Hill, the Chairman, CEO...

PMC Series: Interview with William Dalton, Ph.D M.D., Founder and Executive Chair of M2Gen

Slone Partners’ 2018 PMC Interview Series continues with an exclusive, in-depth interview with William Dalton Ph.D M.D., the Founder and Executive...

PMC Series: Interview with David King, Chairman and CEO of LabCorp

Slone Partners’ 2018 PMC Interview Series continues with an exclusive, in-depth interview with David P. King, the Chairman and CEO of...

Slone Partners, Where People Are Our Science®, Announces Insights: Scientific Healthcare Investing 2018 Panel Event With Leaders In The Investment Community

Produced in conjunction with Biocom, the October 25, 2018 discussion in South San Francisco explores the capital markets and conditions driving innovative companies...

PMC Series: Interview with Daniel O’Day, CEO of Roche Pharmaceuticals

Slone Partners’ 2018 PMC Interview Series debuts with an exclusive, in-depth interview of Daniel O’Day, the CEO of Roche Pharmaceuticals. A...

Biocom Slone Partners Culture

Snapshots & Sound Bites from Biocom + Slone Partners’ INSIGHTS: Culture as a Cornerstone, Bay Area Perspectives

The latest in our series of dynamic live programming Slone Partners produces in major U.S. healthcare hubs addressed the essentials of...